PEARCE CATHERINE (Chief Operating Officer) purchased 2.25K shares of CINCOR PHARMA, INC. on the open market
Open‑market purchase worth $36.0K. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 1/13/2022ACC: 0001209191-22-003190
Officer· Chief Operating Officer
Since Jan 2022
+2.25K
Net shares
Net buyer
$36.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
2.25K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+750.00
Price / share
$16.00
Trade value
$12K
% of position
0.6%
1/11/2022
130.16K→130.91K
Common Stock
Indirect
Shares
+1.50K
Price / share
$16.00
Trade value
$24K
% of position
New position
1/11/2022
0.00→1.50K
Total
Net shares
+2.25K
Net value
$36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/11/2022 | P · Purchase | +750.00 | $16.00 | $12K | 0.6% | 130.16K | 130.91K |
| Common Stock Indirect | 1/11/2022 | P · Purchase | +1.50K | $16.00 | $24K | New position | 0.00 | 1.50K |
| Total | +2.25K | $36K | ||||||
Derivative Transactions0
No derivative transactions reported